Zung Self-Rating Depression Scale

Abstract

The Zung Self-Rating Depression Scale (SDS) is an established 20-item self-report assessment instrument designed to quantify the psychological, affective, and somatic severity of depressive symptoms in adult populations. Developed in 1965 by psychiatrist William W.K. Zung at Duke University Medical Center, the instrument addresses a critical requirement in psychiatric epidemiology and clinical trial research: an efficient, standardized, and patient-centered measurement tool sensitive to symptom changes during therapeutic interventions. The 20 items operationalize core diagnostic criteria for depressive disorders, distributed across pervasive affective disturbances, physiological (somatic) dysfunctions, psychomotor alterations, and cognitive-psychological impairments. Respondents evaluate the frequency of each symptom over the past week using a four-point Likert-type scale ranging from 1 (“A little of the time”) to 4 (“Most or all of the time”). To minimize response bias and acquiescence effects, the scale incorporates a balanced scoring design comprising 10 symptom-positive (negatively worded) items and 10 symptom-negative (positively worded, reverse-scored) items. Cumulative raw scores range from 20 to 80, typically converted into an SDS Index score ranging from 25 to 100. Extensively validated internationally and translated into dozens of languages—including a notable Dutch adaptation by Dijkstra in 1973—the SDS consistently demonstrates robust psychometric properties, including high internal consistency (Cronbach’s alpha typically spanning .79 to .92), satisfactory test-retest stability, and strong convergent validity with clinician-rated benchmarks such as the Hamilton Rating Scale for Depression (HRSD) and alternative self-reports like the Beck Depression Inventory (BDI). This article presents an exhaustive psychometric review of the SDS, analyzing its theoretical underpinnings, structural validity, factor analytic findings, scoring methodology, and contemporary clinical utility.

Keywords

Zung Self-Rating Depression Scale, SDS, psychometrics, depression assessment, depressive symptomatology, somatic symptoms, rating scales, internal consistency, affective disorders, psychiatric evaluation

Authors

The Zung Self-Rating Depression Scale was conceptualized, operationalized, and validated by William W.K. Zung, M.D. (1929–1992). At the time of the instrument’s development and publication, Dr. Zung was a faculty member in the Department of Psychiatry at Duke University School of Medicine and served as a research psychiatrist at the Veterans Administration Hospital in Durham, North Carolina, USA. Dr. Zung was an authority on psychiatric rating methodology, biological psychiatry, and sleep architecture in affective disorders, publishing over one hundred scholarly works evaluating the epidemiology, somatic profile, and pharmacotherapy of mood and anxiety disorders.

Subsequent psychometric adaptations have occurred globally, including the prominent Dutch linguistic and cultural standardization conducted by P. Dijkstra in 1973, which facilitated the scale’s broad implementation throughout psychiatric, primary care, and rehabilitative settings in the Netherlands and Flanders.

Purpose

The primary purpose of the Zung Self-Rating Depression Scale is to measure the severity of depressive illness in individuals presenting with symptoms consistent with mood disorders, functioning as an objective dimensional marker of affective disturbance rather than a categorical diagnostic system. Dr. Zung established the scale to satisfy several methodological and clinical demands prevalent in mid-twentieth-century psychiatry and continuing into modern practice:

• Dimensional Severity Quantification: The SDS provides a continuous score reflecting the intensity of depression, differentiating mild mood variations from moderate and severe clinical depression.
• Monitoring Treatment Trajectories: The scale was constructed to be longitudinally sensitive to therapeutic response, serving as an outcome measure across clinical trials, pharmacotherapy protocols, psychotherapeutic treatments, and electroconvulsive therapy (ECT).
• Comprehensive Somatic and Cognitive Coverage: Unlike self-report tools that focus predominantly on subjective emotional states or cognitive schemas, the SDS gives substantial weight to physiological and vegetative disturbances (e.g., sleep architecture disruption, appetite shifts, constipation, tachycardia, and diurnal mood variation), capturing the systemic nature of major depression.
• Facilitating Large-Scale Screening: With a typical administration duration of under 10 minutes, the SDS functions effectively in epidemiological surveys, general medical settings, outpatient psychiatric clinics, and occupational health screenings.

Importantly, the theoretical rationale emphasizes that while depression manifests intrapsychically, its physiological sequelae are often the primary presenting complaint in primary health care environments. Consequently, an instrument capturing both psychological experiences (e.g., hopelessness, crying spells, suicidal ideation) and neurovegetative functions enables clinicians to identify masked or somatized depressions that might otherwise elude early intervention.

Psychological Construct

The Zung Self-Rating Depression Scale assesses major depressive illness as a multidimensional construct characterized by four interrelated symptom clusters: pervasive affect, physiological disturbances, psychomotor disturbances, and psychological disturbances. Each item is anchored to observable phenomena or subjective states commonly identified in empirical nosologies of mood pathology:

1. Pervasive Affect

This domain taps the core subjective feeling-tone of depressive states, reflecting the patient’s emotional valence. It encompasses:

• Depressed Mood: Manifested in feelings of sadness, dejection, melancholy, and feeling “down-hearted and blue” (Item 1).
• Affective Lability / Crying: Expressed as unprovoked weeping episodes, paroxysmal tearing, or an inability to inhibit crying behavior (Item 3).

2. Physiological (Somatic / Vegetative) Disturbances

Representing half of the instrument’s total item composition, this dimension operationalizes the physiological disruptions driven by hypothalamic-pituitary-adrenal (HPA) axis dysregulation and autonomic nervous system alterations:

• Diurnal Variation: Symptoms exhibiting rhythmic morning exacerbation versus evening improvement (Item 2), a classic marker of melancholia.
• Sleep Impairment: Insomnia, middle-of-the-night awakenings, and initial or terminal sleep maintenance difficulties (Item 4).
• Appetite and Weight Changes: Hypophagia, reduction of food intake, and consequent unintended weight loss (Items 5 and 7).
• Sexual Dysfunction: Loss of libido, hyposexuality, and diminished sexual pleasure (Item 6).
• Gastrointestinal and Autonomic Alterations: Somatosensory complaints such as functional constipation (Item 8), paroxysmal tachycardia or palpitations (Item 9), and generalized asthenia or unexplained physical exhaustion (Item 10).

3. Psychomotor Disturbances

Depression frequently alters baseline psychomotor activity, manifesting along a continuum of motor slowing or heightened inner agitation:

• Psychomotor Agitation: Subjective and physical restlessness, akathisia-like sensations, and inability to maintain physical stillness (Item 13).
• Psychomotor Retardation: Volitional inertia, subjectively experienced as finding standard daily activities laborious and effortful (Item 12).

4. Psychological Disturbances

This cognitive-existential dimension measures depressive processing, self-evaluation, and future orientations:

• Cognitive Clarity and Decisiveness: Mental slowing, impaired executive concentration, and ambivalence in routine decision-making (Items 11 and 16).
• Suicidal Ideation and Value Devaluation: Thoughts of self-harm, passive death wishes, and the conviction that “others would be better off if I were dead” (Item 19).
• Anhedonia and Empty Life: Inability to experience pleasure from previously rewarding activities (anhedonia) and subjective emptiness (Items 18 and 20).
• Irritability and Dysphoria: Heightened interpersonal reactivity, emotional frustration, and low distress tolerance (Item 15).
• Hopelessness and Demoralization: Negative cognitive projections regarding the future, feelings of worthlessness, and perceived uselessness (Items 14 and 17).

Theoretical Framework

The structural design of the Zung Self-Rating Depression Scale reflects mid-twentieth-century psychiatric conceptualizations that integrated phenomenological psychiatry, early biological psychiatry, and empirical factor models of affective illness. During the early 1960s, psychiatric evaluation relied heavily on psychoanalytic formulation or clinician-based narrative evaluations, both of which suffered from low inter-rater reliability. While the Hamilton Rating Scale for Depression (HRSD, 1960) introduced standardized clinician scoring, Dr. Zung recognized the necessity of quantifying the subjective patient experience independently of examiner bias.

Zung grounded the SDS in the clinical criteria established across comprehensive psychiatric literature, specifically incorporating observations from authors such as Emil Kraepelin, Eugen Bleuler, and Aubrey Lewis regarding melancholia and manic-depressive illness. The fundamental theoretical axioms underpinning the SDS comprise:

• Equivalence of Somatic and Affective Indicators: Zung hypothesized that depressive illness is fundamentally a systemic, psychosomatic disturbance. Somatic manifestations—such as gastrointestinal slowing, cardiovascular reactivity, and circadian disturbances—are not merely secondary consequences of psychological distress, but direct biological correlates of the depressive state.
• Bipolarity of Affective Experiences: To prevent positive or negative acquiescent response bias, the construct presumes that affective health and affective pathology exist along balanced operational continuums. By balancing 10 positively worded and 10 negatively worded statements, Zung forced respondents to process cognitive-affective valence actively rather than relying on automatic affirmation.
• State versus Trait Measurement: The SDS is designed to register the current state of depressive illness rather than enduring, trait-like neuroticism or depressive personality organization. It asks respondents to calibrate their responses according to recent temporal frequency, ensuring that the metric captures transient fluctuations induced by clinical remission or deterioration.

Validity

The psychometric validity of the Zung Self-Rating Depression Scale has been established across clinical, geriatric, and community samples worldwide.

Construct and Criterion Validity

Construct validity was initially documented by Zung (1965) through known-groups validation: psychiatric inpatients diagnosed with depressive disorders scored significantly higher on the SDS (mean index score = 74) than psychiatric patients with non-depressive diagnoses (mean index score = 53) and healthy normal controls (mean index score = 33). Subsequent large-scale clinical trials have consistently replicated this discriminant capability, demonstrating that the scale accurately categorizes individuals across distinct severity strata.

Convergent and Concurrent Validity

Concurrent validity has been established by evaluating correlations between the SDS and established measures of depressive pathology:

• Hamilton Rating Scale for Depression (HRSD): Bivariate correlations between the clinician-rated HRSD and the patient-rated SDS regularly fall within the moderate-to-high range ($r = .65$ to $.80$), confirming strong congruence between external clinical observation and subjective patient appraisal.
• Beck Depression Inventory (BDI): Cross-validation studies indicate strong concurrent alignment with the BDI, with Pearson product-moment correlation coefficients typically reported between $r = .73$ and $.86$.
• Minnesota Multiphasic Personality Inventory (MMPI): The SDS demonstrates selective convergence with the MMPI Depression (D) Clinical Scale ($r = .60$ to $.70$), while showing lower correlations with non-affective subscales.

Discriminant Validity

While the SDS effectively differentiates major depressive disorder from healthy functioning, its somatic component introduces significant overlap with generalized anxiety disorder and chronic medical illnesses. Somatic items (e.g., tachycardia, fatigue, constipation) can elevate overall scores in medically ill populations (such as oncology, renal, or post-stroke patients) in the absence of primary depressive illness. Psychometricians recommend evaluating the cognitive-affective items independently when administering the instrument to populations with severe comorbid physical conditions.

Reliability

The reliability of the Zung Self-Rating Depression Scale has been examined across diverse sociocultural contexts, demonstrating consistency and temporal stability:

• Internal Consistency: Across psychiatric and general population samples, the scale yields robust internal consistency indices. Cronbach’s alpha coefficients typically fall between $\alpha = .79$ and $.92$. Split-half reliability coefficients, calculated utilizing the Spearman-Brown prophecy formula, have historically demonstrated values ranging from $.73$ to $.87$.
• Test-Retest Reliability: In stable, unmedicated outpatient cohorts assessed across intervals ranging from one to four weeks, test-retest reliability coefficients span $r = .70$ to $.88$, demonstrating adequate longitudinal consistency. Following successful pharmacological or psychotherapeutic treatment, SDS scores drop significantly, confirming the scale’s sensitivity to clinical change.
• Item-Total Correlations: The majority of items demonstrate corrected item-total correlations exceeding $r = .40$. Items assessing core psychological features (such as Item 1 “down-hearted and blue” and Item 19 “better off dead”) demonstrate the highest item-total correlations ($r > .60$), whereas certain isolated somatic items (such as Item 8 “constipation” and Item 9 “tachycardia”) exhibit lower, yet statistically significant, item-total correlations ($r = .25$ to $.40$).

Factor Analysis

Extensive exploratory (EFA) and confirmatory factor analyses (CFA) have been conducted on the SDS to evaluate whether its 20 items converge onto a single global depression factor or a multidimensional configuration. Although Zung originally proposed four theoretical domains, empirical investigations across diverse cultural and psychiatric cohorts consistently identify between three and four robust latent factors:

Common Empirical Factor Solutions

• Factor 1: Core Depressive Affect / Cognitive Demoralization: This dominant factor accounts for the largest proportion of total variance (often 25% to 35%) and comprises items assessing sadness, crying spells, hopelessness, personal devaluation, emptiness, and suicidal ideation (Items 1, 3, 14, 17, 18, 19, and 20). Factor loadings for these items are consistently high ($lambda = .55$ to $.82$).
• Factor 2: Somatic / Vegetative Dysfunction: Capturing neurobiological disruptions, this factor encompasses sleep architecture failure, appetite reduction, weight loss, constipation, and unexplained fatigue (Items 4, 5, 7, 8, 10). Factor loadings typically range from $.40$ to $.70$.
• Factor 3: Psychomotor and Cognitive Efficiency: This factor captures volitional and mental processing speed, characterized by mental clarity, decisiveness, ease of functioning, and motor restlessness (Items 11, 12, 13, 16).
• Factor 4: Autonomic and Irritability Symptoms (in 4-factor models): Some studies isolate tachycardia, irritability, and decreased libido (Items 6, 9, 15) into a discrete autonomic reactivity or interpersonal strain component.

Confirmatory factor analytic investigations examining hierarchical models indicate that while a multidimensional structure best accounts for item-level variance, a higher-order overarching “General Depression” factor accounts for the shared covariance among sub-dimensions, supporting the use of a single composite index score in clinical decision-making.

Instrument / Measurement Tool

• Instrument Name: Zung Self-Rating Depression Scale (SDS)
• Construct Measured: Severity of depressive symptomatology (affective, cognitive, somatic, and psychomotor)
• Test Type: Self-administered questionnaire / psychometric rating scale
• Target Population: Adults (aged 18 and older); adaptable for geriatric populations
• Administration Time: Approximately 5 to 10 minutes
• Item Count: 20 items
• Response Scale: 4-point Likert-type scale:
  • 1 = A little of the time (None or a little of the time)
  • 2 = Some of the time
  • 3 = A good part of the time
  • 4 = Most or all of the time
• Scoring and Transformation Rules:
  • Symptom-Positive Items (Negatively Worded, Scored 1 to 4): Items 1, 3, 4, 7, 8, 9, 10, 13, 15, and 19. A rating of “A little of the time” = 1, “Some of the time” = 2, “A good part of the time” = 3, “Most or all of the time” = 4.
  • Symptom-Negative Items (Positively Worded, Reverse-Scored 4 to 1): Items 2, 5, 6, 11, 12, 14, 16, 17, 18, and 20. A rating of “A little of the time” = 4, “Some of the time” = 3, “A good part of the time” = 2, “Most or all of the time” = 1.
  • Raw Score Range: 20 to 80 points.
  • SDS Index Calculation: Converted to a 100-point scale using the formula:
    SDS Index = (Raw Score / 80) × 100
• Clinical Interpretive Cut-Offs (SDS Index):
  • Below 50: Within normal limits (No significant psychopathology)
  • 50 – 59: Mild to moderate depression
  • 60 – 69: Moderate to marked (severe) depression
  • 70 and above: Severe to extreme depression

Permissions & Fee and Test Year

The Zung Self-Rating Depression Scale was initially published by Dr. William W.K. Zung in 1965 in the Archives of General Psychiatry (now JAMA Psychiatry). The original scale was placed in the public scientific domain for academic, clinical, and scientific research purposes. As a result, no licensing fees or administrative royalties are typically required for non-commercial research, academic investigations, or individual clinical use. However, researchers, commercial test publishers, and institutional users intending to embed the scale within commercial diagnostic software or proprietary electronic medical records systems must verify local copyright provisions and appropriately cite the original 1965 publication.

References

• Dijkstra, P. (1973). De betrouwbaarheid en validiteit van de Zung Self-Rating Depression Scale in een Nederlandse populatie [The reliability and validity of the Zung Self-Rating Depression Scale in a Dutch population]. Nederlands Tijdschrift voor de Psychologie en haar Grensgebieden, 28(6), 401–415.
• Dunstan, D. A., & Scott, N. (2019). Clarification of the cut-off score for Zung’s Self-Rating Depression Scale. BMC Psychiatry, 19(1), 177. https://doi.org/10.1186/s12888-019-2165-6
• Gabrys, J. B., & Peters, K. (1985). Reliability, discriminant and convergent validity of the Zung Self-Rating Depression Scale. Psychological Reports, 57(3_suppl), 1091–1096. https://doi.org/10.2466/pr0.1985.57.3f.1091
• Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56–62. https://doi.org/10.1136/jnnp.23.1.56
• Knight, R. G., Waal-Manning, H. J., & Spears, G. F. (1983). Some norms and reliability data for the State-Trait Anxiety Inventory and the Zung Self-Rating Depression Scale. British Journal of Clinical Psychology, 22(4), 245–249. https://doi.org/10.1111/j.2044-8260.1983.tb00610.x
• Zung, W. W. K. (1965). A self-rating depression scale. Archives of General Psychiatry, 12(1), 63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008
• Zung, W. W. K. (1967). The depression status inventory: An adjunct to the self-rating depression scale. Journal of Clinical Psychology, 23(2), 178–181. https://doi.org/10.1001/archpsyc.1965.01730060026004

13. Items of the Scale (Questionnaire)